Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.

Market Analysis and Insights: Global Oxytocic Pharmaceuticals Market
The global Oxytocic Pharmaceuticals market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Oxytocic Pharmaceuticals Scope and Market Size
The global Oxytocic Pharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oxytocic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Natural Oxytocin
Synthetic Oxytocin Derivative

Segment by Application
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest

The Oxytocic Pharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Oxytocic Pharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva